MFN2 and Charcot-Marie-Tooth disease: This vertebrate model supports a role for loss of MFN2 function in the progressive motor dysfunction observed in some CMT type 2A and HMSN type VI patients, and reinforce the importance of evaluating MFN2 mutation state in recessive cases of axonal CMT.